| Literature DB >> 35672523 |
Daisuke Kanamori1, Masashi Kurobe2, Tetsuro Sugihara2, Atsushi Harada2, Sayuri Kaji2, Goki Uchida2, Yuji Baba2, Shinsuke Ohashi2, Shuichi Ashizuka2, Takao Ohki2.
Abstract
PURPOSE: An increase in the incidence of pediatric complicated appendicitis (CA) during the COVID-19 pandemic has been reported in many countries. We investigated how the pandemic has affected Japan.Entities:
Keywords: Acute appendicitis; COVID-19; Complicated appendicitis; Duration of symptoms; Pediatrics
Year: 2022 PMID: 35672523 PMCID: PMC9172983 DOI: 10.1007/s00595-022-02529-0
Source DB: PubMed Journal: Surg Today ISSN: 0941-1291 Impact factor: 2.540
Fig. 1Changes in the number of COVID-19-positive cases from January 1 to October 31, 2020, in the prefectures where the facilities are located
Fig. 2Changes in the number of hospitalized patients with acute appendicitis and incidence of complicated appendicitis every 2 months
Fig. 3Rate of change in the number of inpatients at each institution before and after the pandemic period [what is ‘after the pandemic’? The pandemic is still ongoing. Weren’t you comparing before and during the pandemic?]. Facilities A and B are in urban areas, whereas facilities C, D, and E are in the suburbs
Clinical findings in all facilities and the three facilities where the number of hospitalizations decreased during both the pandemic and non-pandemic periods
| All facilities | Three facilities with decreased hospitalizations | |||||
|---|---|---|---|---|---|---|
| 2017–2019 ( | 2020 ( | 2017–2019 ( | 2020 ( | |||
| Age (years) | 10 (9–13) | 11 (7–13) | 0.31 | 10.5 (9–13) | 11 (7–12) | 0.23 |
| Male gender | 110 (57%) | 31 (56%) | 0.90 | 71 (58%) | 15 (52%) | 0.53 |
| Incidence of CA | 35 (18.2%) | 18 (32.7%) | 0.02 | 20 (16.4%) | 11 (37.9%) | 0.01 |
| Duration of PSa (days) | 1.4 ± 1.2 | 1.5 ± 1.1 | 0.28 | 1.3 ± 1.1 | 1.7 ± 1.0 | 0.03 |
| WBC | 14,500 (12,300–17,500) | 15,700 (12,950–17,900) | 0.11 | 14,700 (12,850–17,775) | 15,600 (12,700–18,100) | 0.24 |
| CRP | 2.06 (0.28–6.66) | 2.53 (0.42–8.64) | 0.48 | 1.62 (0.24–5.65) | 3.08 (0.66–7.42) | 0.22 |
| BT | 37.5 (37.0–38.0) | 37.5 (37.0–38.3) | 0.61 | 37.4 (37.0–37.9) | 37.4 (37.0–37.7) | 0.50 |
| Length of stay (days) | 6.0 (5.0–7.0) | 6.0 (5.0–8.0) | 0.56 | 5.0 (4.0–7.0) | 6.5 (5.0–8.8) | 0.11 |
Data are expressed as the median (interquartile range)
PS pre-operative symptoms, BT body temperature
aData are expressed as the mean ± standard deviation